AGN - Allergan
This page shows which of the focused investors we track hold AGN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2013 it was held by 3 managers with an aggregate reported value of $252.95M, which is 0.04% of the combined portfolio.
As of Q3 2013, 3 tracked institutional managers held AGN (Allergan) with an aggregate reported value of $252.95M — 0.04% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades AGN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2013
- Ticker
- AGN
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Polen Capital Management - Polen Capital Management | 5.82% | Reduce -5.6% | 2,792,480 | $252.58M |
| 2 | Dodge & Cox - Dodge & Cox | 0.00% | - | 3,564 | $322K |
Call holders — bullish via leverage
1 manager holds call options on AGN — a right to buy at strike. Notional value, not premium.
| 1 | Daniel Loeb - Third Point | New | 17,500 | $51K |
Loading holder history for AGN…